| View |
|
DRP-10842
|
Tretinoin
|
Saphtinoin
|
250 mcg/g (0.025% w/w)
|
Topical Cream
|
Anti-Acne
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial (OTC)
|
06 December 2021
|
06 December 2026
|
| View |
|
DRP-10837
|
Retinol (as palmitate) (Vitamin A)
|
Retisol-A
|
200,000 IU
|
Softgel Capsule
|
-
|
Kanion Pharmaceutical Co., Ltd.
|
China
|
Initial OTC
|
23 August 2022
|
03 December 2026
|
| View |
|
DRP-10861
|
Ascorbic Acid
|
Vitadix-C
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection
(IM/IV/SC)
|
Vitamin
|
Scott-Edil Pharmacia Limited
|
India
|
Initial
|
09 December 2021
|
09 December 2026
|
| View |
|
HMRP-31
|
Vitex Negundo L. (Lagundi Leaf)
|
Ascof Forte
(Menthol Flavor)
|
600 mg/ 5 mL
|
Syrup
|
Herbal Medicine (Anti-cough/Anti-asthma)
|
Pascual Laboratories, Inc.
|
Philippines
|
Renewal
|
23 May 2022
|
29 January 2027
|
| View |
|
HMRP-30
|
Vitex negundo L. (Lagundi Leaf)
|
Ascof (Ponkan Flavor)
|
300 mg/ 5 mL
|
Syrup
|
-
|
Pascual Laboratories
|
Philippines
|
Initial (Variation)
|
16 November 2022
|
10 August 2027
|
| View |
|
HMRP-29
|
Vitex Negundo L.
(Lagundi) Leaves
|
Ascof Syrup
(Strawberry Flavor)
|
300 mg/ 5 mL
|
Syrup
|
Herbal Medicine (Anti-cough/Anti-asthma)
|
Pascual Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 June 2023
|
01 August 2028
|
| View |
|
DRP-10868
|
Ascorbic Acid + Zinc
|
Protec-Zinc
|
533.40 mg (equivalent to 600 mg Sodium Ascorbate) +
10 mg (equivalent to 27.45 Zinc Sulfate)
|
Capsule
|
Vitamin/Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
PCPR
|
09 December 2021
|
30 October 2025
|
| View |
|
DRP-10867
|
Erlotinib (as hydrochloride)
|
Tarlonib 25
|
25 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Initial (PCPR Conversion) (Reconstruction)
|
27 June 2024
|
30 April 2026
|
| View |
|
DRP-10866
|
Erlotinib (As Hydrochloride)
|
Tarlonib 100
|
100 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
PCPR
|
09 December 2021
|
30 April 2026
|
| View |
|
DRP-10865
|
Erlotinib (as hydrochloride)
|
Tarlonib 150
|
150 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Initial (PCPR Conversion) (Reconstruction)
|
27 June 2024
|
30 April 2026
|
| View |
|
DRP-10864
|
Ambroxol Hydrochloride
|
Expel Od
|
75 mg
|
Sustained-Release Capsule
|
Mucolytic
|
Inventia Healthcare Limited
|
India
|
PCPR
|
09 December 2021
|
05 February 2025
|
| View |
|
DR-XY35130
|
Cromolyn Sodium
|
Cromax-4
|
40mg/mL (4%w/v)
|
Sterile Ophthalmic Solution (eye drops)
|
Anti-Allergy
|
Laboratorios Ashford Limitida
|
China
|
Automatic Renewal
|
09 December 2021
|
12 March 2026
|
| View |
|
DR-XY29403
|
Cefalexin (As Monohydrate)
|
Profalexin
|
100 mg/mL
|
Granules For Suspension (Oral Drops)
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Re-issuance)
|
02 August 2022
|
14 January 2026
|
| View |
|
DR-XY47602
|
Rosuvastatin (as calcium) + Clopidogrel (as bisulfate)
|
Turbovas-CP
|
5 mg/75 mg
|
Capsule*
[*Rosuvastatin film-coated tablet enclosed in a hard
gelatin capsule with the Clopidogrel powder blend]
|
Lipid Modifying Agent-Antithrombotic Agent
Combination
|
Micro Labs Limited
|
India
|
Monitored Release
|
10 December 2021
|
10 December 2026
|
| View |
|
DR-XY47597
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Asulbac
|
1g/ 500mg
|
Powder for Injection (I.V./I.M.)
|
Antibacterial (Penicillin-Beta-lactamase Inhibitor
Combination)
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
Initial
|
09 December 2021
|
09 December 2026
|
| View |
|
DR-XY47593
|
Budesonide
|
None
|
250 mcg/mL (500 mcg/
2mL)
|
Suspension for Nebulization
|
Glucocorticoid
|
Cipla Ltd. (Unit I)
|
India
|
Initial
|
09 December 2021
|
09 December 2026
|
| View |
|
DRP-10871
|
Diclofenac Potassium
|
None
|
50 mg
|
Granules for Oral Solution
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial (Re-issuance)
|
19 August 2022
|
09 December 2026
|
| View |
|
DRP-6830-02
|
Cefuroxime (As Axetil)
|
None
|
500 mg
|
Film-Coated Tablet
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP
|
10 December 2021
|
17 February 2025
|
| View |
|
DRP-7192-01
|
Letrozole
|
Triazol
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic (Aromatase Inhibitor)
|
Intas Pharmaceuticals Limited
|
India
|
CLIDP
|
14 December 2021
|
11 October 2025
|
| View |
|
DRP-10878
|
Clopidogrel (as bisulfate)
|
Plasmabloc
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent
(Platelet Aggregation Inhibitor)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
10 December 2021
|
10 December 2026
|